Skip to content

Insider · CIK 0001472122

Andrew Arno

director

Files at SMSI (SMITH MICRO SOFTWARE, INC.), XXII (22nd Century Group, Inc.), IMDX (Oncocyte Corp), VJET (Catheter Precision, Inc.). First filing Dec 26, 2024, latest Dec 26, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$26k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

IMDX: Oncocyte Corp

IMDXOct 9, 2026 · close 3.37

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
31Weak
IMDXbuy 2
Oncocyte Corp
$26k
12,500 shares
+18%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 10, 2025XXII
22nd Century Group, Inc.
AGrant or award
Common Stock
+4,237$0.00$04,284Mar 12, 2025
Mar 10, 2025XXII
22nd Century Group, Inc.
AGrant or award
Non-Qualified Stock Optionderivative
+12,713$0.00$012,713Mar 12, 2025
Jan 29, 2025VJET
Catheter Precision, Inc.
AGrant or award
Stock Optionderivative
+100,000$0.00$0100,000Jan 31, 2025
Jan 23, 2025SMSI
SMITH MICRO SOFTWARE, INC.
AGrant or award
Common Stock
+25,000$0.00$067,514Jan 27, 2025
Dec 26, 2024IMDX
Oncocyte Corp
POpen-market purchase
Common Stock, no par value
+12,500$2.11$26k81,554Dec 26, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Andrew Arno: insider trades and track record | InsiderTell